$0.859
-0.021 (-2.39%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
CytoMed Therapeutics Ltd (GDTC) Moving Averages Convergence Divergence (MACD) indicator is -0.00, suggesting GDTC is Strong sell.
CytoMed Therapeutics Ltd (GDTC) 20-Day simple moving average is 0.89, while CytoMed Therapeutics Ltd (GDTC) share price is $—, making it Sell.
CytoMed Therapeutics Ltd (GDTC) 60-Day simple moving average is 0.90, while CytoMed Therapeutics Ltd (GDTC) share price is $—, making it Sell.
Technical Analysis for GDTC
AI Technical GDTCAs of 2026-11-07, the technical board for CytoMed Therapeutics Ltd (GDTC) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $0.86 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 44.128, MACD stands at -0.00377 (Sell), Stochastic %K stands at 52.063, Stochastic %D stands at 65.31 and CCI stands at -92.243.
GDTC trades below the 60-day SMA (0.90) and below the 200-day SMA (0.98). Immediate resistance sits at Classic R1 0.96, then R2 1.02. Support sits at Classic S1 0.82, then S2 0.74.
CytoMed Therapeutics Ltd (GDTC) Support & Resistance Level
CytoMed Therapeutics Ltd (GDTC) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 44.128 |
| STOCHk_14_3_3 | 52.063 |
| STOCHd_14_3_3 | 65.310 |
| CCI_20 | -92.243 |
| AO_5_34 | -0.010 |
| MOM_10 | -0.060 |
| MACD_12_26_9 | -0.004 |
CytoMed Therapeutics Ltd (GDTC) Relative Strength Index (RSI_14) is 44.128, creating a Neutral signal.
CytoMed Therapeutics Ltd (GDTC) Stochastic %K is 52.063, creating a Neutral signal.
CytoMed Therapeutics Ltd (GDTC) Stochastic %D is 65.310, creating a Neutral signal.
CytoMed Therapeutics Ltd (GDTC) CCI_20 is -92.243, creating a Neutral signal.
CytoMed Therapeutics Ltd (GDTC) Awesome Oscillator (AO) is -0.010, creating a Sell signal.
CytoMed Therapeutics Ltd (GDTC) Momentum (MOM) is -0.060, creating a Sell signal.
CytoMed Therapeutics Ltd (GDTC) Moving Average Convergence Divergence (MACD) is -0.004, creating a Sell signal.
CytoMed Therapeutics Ltd (GDTC) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.890 | Sell |
| MA_10 | 0.902 | Sell |
| MA_20 | 0.890 | Sell |
| MA_60 | 0.904 | Sell |
| MA_200 | 0.976 | Sell |
| MA_250 | 1.095 | Sell |
CytoMed Therapeutics Ltd (GDTC) 5-Day simple moving average is 0.890, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
CytoMed Therapeutics Ltd (GDTC) 10-Day simple moving average is 0.902, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
CytoMed Therapeutics Ltd (GDTC) 20-Day simple moving average is 0.890, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
CytoMed Therapeutics Ltd (GDTC) 60-Day simple moving average is 0.904, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
CytoMed Therapeutics Ltd (GDTC) 200-Day simple moving average is 0.976, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
CytoMed Therapeutics Ltd (GDTC) 250-Day simple moving average is 1.095, while CytoMed Therapeutics Ltd (GDTC) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.